Are IL-23 inhibitors too slow to have a therapeutic success in plaque psoriasis? A real-life experience of 330 patients.

Licata, Gaetano; Buononato, Dario; Tancredi, Vittorio; Calabrese, Giulia; DE Rosa, Alina; Argenziano, Giuseppe; Gambardella, Alessio

Licata, Gaetano; Buononato, Dario; Tancredi, Vittorio; Calabrese, Giulia; DE Rosa, Alina; Argenziano, Giuseppe; Gambardella, Alessio.

Afiliación

Licata G; Department of Dermatology, ASST Spedali Civili di Brescia, University of Brescia, Brescia, Italy - gaetano.licata89@gmail.com.
Buononato D; Unit of Dermatology, Luigi Vanvitelli University of Campania, Naples, Italy.
Tancredi V; Unit of Dermatology, Luigi Vanvitelli University of Campania, Naples, Italy.
Calabrese G; Unit of Dermatology, Luigi Vanvitelli University of Campania, Naples, Italy.
DE Rosa A; Unit of Dermatology, Luigi Vanvitelli University of Campania, Naples, Italy.
Argenziano G; Unit of Dermatology, Luigi Vanvitelli University of Campania, Naples, Italy.
Gambardella A; Unit of Dermatology, Luigi Vanvitelli University of Campania, Naples, Italy.

Ital J Dermatol Venerol ; 158(3): 263-265, 2023 06.

Article en En | MEDLINE | ID: mdl-37278503

Asunto(s)

Inhibidores de Interleucina; Psoriasis; Humanos; Psoriasis/tratamiento farmacológico; Anticuerpos Monoclonales/uso terapéutico; Interleucina-23/uso terapéutico

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Inhibidores de Interleucina Límite: Humans Idioma: En Revista: Ital J Dermatol Venerol Año: 2023 Tipo del documento: Article Pais de publicación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google